ask="70.00"
ask_size="500"
average_daily_volume="600403"
bid="66.37"
bid_size="100"
book_value="9.91"
change="-1.41"
change_from_200_day_moving_average="20.16"
change_from_50_day_moving_average="13.95"
change_from_52_week_high="-1.76"
change_From_52_week_low="41.12"
change_in_percent="-2.05%"
close="67.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.75"
ebitda="-159.90M"
eps_estimate_current_year="-6.68"
eps_estimate_next_quarter="-1.64"
eps_estimate_next_year="-6.00"
ex_dividend_date="N/A"
float_shares="33673000"
high="69.16"
high_52_weeks="69.16"
last_trade_date="2/28/2017"
last_trade_price="67.40"
last_trade_size="42279"
last_trade_time="4:00pm"
low="67.08"
low_52_weeks="26.28"
market_capitalization="2.51B"
moving_average_200_day="47.24"
moving_average_50_day="53.45"
name="Sage Therapeutics
Inc."
notes="N/A"
one_year_target_price="83.08"
open="68.94"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+42.67%"
percent_change_from_50_day_moving_average="+26.09%"
percent_change_from_52_week_high="-2.54%"
percent_change_from_52_week_low="+156.47%"
previous_close="68.81"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.95"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37198000"
short_ratio="8.74"
stock_exchange="NGM"
symbol="SAGE"
volume="586703"
weeks_range_52="26.28 - 69.16"
